Raymond James & Associates’s Cassava Sciences SAVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $2.02M | Sell |
68,671
-8,288
| -11% | -$244K | ﹤0.01% | 2209 |
|
|
2024
Q2 | $950K | Buy |
76,959
+912
| +1% | +$11.3K | ﹤0.01% | 2640 |
|
|
2024
Q1 | $1.54M | Buy |
76,047
+1,950
| +3% | +$39.6K | ﹤0.01% | 2319 |
|
|
2023
Q4 | $1.67M | Buy |
74,097
+565
| +0.8% | +$12.7K | ﹤0.01% | 2194 |
|
|
2023
Q3 | $1.22M | Buy |
73,532
+12,129
| +20% | +$202K | ﹤0.01% | 2322 |
|
|
2023
Q2 | $1.51M | Sell |
61,403
-3,261
| -5% | -$80K | ﹤0.01% | 2226 |
|
|
2023
Q1 | $1.56M | Buy |
64,664
+3,592
| +6% | +$86.6K | ﹤0.01% | 2177 |
|
|
2022
Q4 | $1.8M | Buy |
61,072
+2,386
| +4% | +$70.5K | ﹤0.01% | 2051 |
|
|
2022
Q3 | $2.45M | Buy |
58,686
+13,656
| +30% | +$571K | ﹤0.01% | 1841 |
|
|
2022
Q2 | $1.27M | Sell |
45,030
-8,577
| -16% | -$241K | ﹤0.01% | 2293 |
|
|
2022
Q1 | $1.99M | Buy |
53,607
+9,916
| +23% | +$368K | ﹤0.01% | 2130 |
|
|
2021
Q4 | $1.91M | Buy |
43,691
+5,604
| +15% | +$245K | ﹤0.01% | 2207 |
|
|
2021
Q3 | $2.36M | Buy |
38,087
+19,945
| +110% | +$1.24M | ﹤0.01% | 1983 |
|
|
2021
Q2 | $1.55M | Sell |
18,142
-2,489
| -12% | -$213K | ﹤0.01% | 2283 |
|
|
2021
Q1 | $927K | Buy |
+20,631
| New | +$927K | ﹤0.01% | 2562 |
|